Revenue ($USD) : $9,455,400,000
Revenue (foreign currencies) : €8,755,000,000
R&D spend : $523,368,000
Employees : 63,011
Fiscal year end : 12/31/2023
CEO : Anna Maria Braun, CEO; Rob Albert, U.S. CEO

www.bbraun.com

With more than 300 subsidiaries in 64 countries, B. Braun Melsungen manufactures over 5,000 medical devices and pharmaceutical products, which it supplements with an extensive range of services. B. Braun has three divisions: Hospital Care, Aesculap (surgical and interventional), and Avitum (chronic disease treatments). Multiple generations of the Braun family have owned the company since its founding in the 19th century, with Anna Maria Braun presently serving as CEO. Despite what company officials described as a demanding environment, sales were up 3% and earnings were up more than 15% in 2023. The U.S. HQ is in Bethlehem, Pennsylvania. –CN